Innovating Works

PHARMALEX GMBH

Desconocido
INSPIRE: Developing novel inhaled bioengineered Extracellular Vesicle RNA based advanced therapeutics, delive... PHARMALEX GMBH participó en un HORIZON EUROPE: HORIZON-HLTH-2021-TOOL-06 Lung cancer (LC) treatments have advanced in recent years with the advent of genetic profiling and immunotherapy. However, LC is a complex h...
2022-05-24 - 2025-05-31 | Financiado
iPSpine: Induced pluripotent stem cell based therapy for spinal regeneration PHARMALEX GMBH participó en un H2020: H2020-SC1-BHC-2018-2020 Low back pain (LBP) is a leading cause of disability and morbidity worldwide. It is widely accepted that a major contributor to LBP is inter...
2018-12-07 - 2024-06-30 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.